![MIPS Seminar - Matthew Bogyo, PhD @ Venue coming soon!](https://web.stanford.edu/group/radweb/cgi-bin/radcalendar/wp-content/uploads/2019/10/BogyoHeadshotJuly2017-244x300.jpg)
MIPS Seminar Series: Title TBA
Matthew Bogyo, PhD
Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology
Stanford University
Location: Coming soon!
12:00pm – 12:45pm Seminar & Discussion
RSVP: Coming soon!
ABSTRACT
Coming soon!
ABOUT
Dr. Bogyo received a B.Sc. degree in Chemistry from Bates College in 1993 and a Ph.D. in Biochemistry from the Massachusetts Institute of Technology in 1997. After completion of his degree he was appointed as a Faculty Fellow in the Department of Biochemistry and Biophysics at the University of California, San Francisco. Dr. Bogyo served as the Head of Chemical Proteomics at Celera Genomics from 2001 to 2003 while maintaining an Adjunct Faculty appointment at UCSF. In the Summer of 2003 Dr. Bogyo joined the Department of Pathology at Stanford Medical School and was appointed as a faculty member in the Department of Microbiology and Immunology in 2004. His interests are focused on the use of chemistry to study the role of proteases in human disease. In particular his laboratory is currently working on understanding the role of cysteine proteases in tumorgenesis and also in the life cycle of human parasites and bacterial pathogens. Dr. Bogyo currently serves on the Editorial Board of Biochemical Journal, Cell Chemical Biology, Molecular and Cellular Proteomics and is an Academic Editor at PLoS One. Dr. Bogyo is a consultant for several biotechnology and pharmaceutical companies in the Bay Area and is a founder and board member of Akrotome Imaging and Facile Therapeutics.
Hosted by: Katherine Ferrara, PhD
Sponsored by: Molecular Imaging Program at Stanford & the Department of Radiology
Indrani Bhattacharya, PhD
Postdoctoral Research Fellow
Department of Radiology
Stanford University
Title: Multimodal Data Fusion for Selective Identification of Aggressive and Indolent Prostate Cancer on Magnetic Resonance Imaging
Abstract: Automated methods for detecting prostate cancer and distinguishing indolent from aggressive disease on Magnetic Resonance Imaging (MRI) could assist in early diagnosis and treatment planning. Existing automated methods of prostate cancer detection mostly rely on ground truth labels with limited accuracy, ignore disease pathology characteristics observed on resected tissue, and cannot selectively identify aggressive (Gleason Pattern≥4) and indolent (Gleason Pattern=3) cancers when they co-exist in mixed lesions. This talk will cover multimodal and multi-scale fusion approaches to integrate radiology images, pathology images, and clinical domain knowledge about prostate cancer distribution to selectively identify and localize aggressive and indolent cancers on prostate MRI.
Rogier van der Sluijs, PhD
Postdoctoral Research Fellow
Department of Radiology
Stanford University
Title: Pretraining Neural Networks for Medical AI
Abstract: Transfer learning has quickly become standard practice for deep learning on medical images. Typically, practitioners repurpose existing neural networks and their corresponding weights to bootstrap model development. This talk will cover several methods to pretrain neural networks for medical tasks. The current challenges for pretraining neural networks in Radiology will be discussed and recent advancements that address these bottlenecks will be highlighted.
Nina Kottler, MD, MS
Associate Chief Medical Officer, Clinical AI
VP Clinical Operations
Radiology Partners
Abstract:
We have a call to action in healthcare – we need to drive value. Artificial intelligence (AI), if deployed correctly, can help accomplish this lofty mission. In this discussion we will review the following lessons learned in deploying radiology AI at scale: 4 unexpected benefits of implementing AI emergent finding triage; the importance of investing in AI radiologist education; how “most” AI needs to be incorporated into the radiologist workflow; why a platform is required to deploy AI at scale and what a modern platform looks like; how to use AI to add value to your data; and, as Dr. Curt Langlotz famously said, why rads (practices) who use AI will replace those who don’t (a depiction of what the role of the radiologist might look like in a tech enabled future).
Bio:
Dr. Kottler has been a practicing radiologist specializing in emergency imaging for over 16 years. Combining her clinical experience with a graduate degree in applied mathematics, she has been using technological innovation to drive value in radiology. As the first radiologist to join Radiology Partners, Dr. Kottler has held multiple leadership positions within her practice and is currently the associate Chief Medical Officer for Clinical AI. Externally Dr. Kottler serves on multiple committees for the ACR, RSNA, and SIIM. Dr. Kottler is also passionate about promoting diversity and creating a culture of belonging. As such she is a member of the AAWR, is a member of the diversity and inclusion committee at SIIM, serves on the steering committee for RAD=, and leads the education and development division of the Belonging Committee within Radiology Partners.
Spyridon (Spyros) Bakas, PhD
Assistant Professor in the Department of Pathology,
Laboratory Medicine, and of Radiology
Center for Biomedical Image Computing and Analytics (CBICA)
Perelman School of Medicine
University of Pennsylvania
Title: Imaging Analytics for Neuro-Oncology:
Towards Computational Diagnostics
Abstract: Central nervous system (CNS) tumors come with vastly heterogeneous histologic, molecular, and radiographic landscapes, rendering their precise characterization challenging. The rapidly growing fields of biophysical modeling and radiomics have shown promise in better characterizing the molecular, spatial, and temporal heterogeneity of tumors. Integrative analysis of CNS tumors, including clinically acquired multi-parametric magnetic resonance imaging (mpMRI), assists in identifying macroscopic quantifiable tumor patterns of invasion and proliferation, potentially leading to improved (a) detection/segmentation of tumor subregions and (b) computer-aided diagnostic/prognostic/predictive modeling. This talk will touch upon example studies on this space, as well as an overview of the largest to-date real-world federated learning study to detect brain tumor boundaries.
Harini Veeraraghavan, PhD
Associate Attending Computer Scientist
Department of Medical Physics
Memorial Sloan-Kettering Cancer Center
Using AI for Longitudinal Tumor Response Monitoring and AI Guided Cancer Treatments: From Lab to Clinic
Abstract:
Cancer patients are imaged with multiple imaging modalities as part of routine cancer care. However, the rich information available from the images are not fully exploited to better manage patient care through earlier intervention as well as more precise targeted treatments. In this talk, I will present some of the new AI methodologies we have been developing to track tumor response as well as from routinely acquired imaging applied to image-guided radiation treatments using CT/cone-beam CT as well as MRI-guided precision treatments. I will also present some demonstration studies of how AI based automated segmentation and tumor as well as healthy tissue change assessment can be used to early detect treatment toxicities to enable clinicians to better manage cancer care. Finally, I will show how these developed methods have been put to routine clinical care for automating radiotherapy treatment planning at MSK.
Spyridon (Spyros) Bakas, PhD
Assistant Professor in the Department of Pathology,
Laboratory Medicine, and of Radiology
Center for Biomedical Image Computing and Analytics (CBICA)
Perelman School of Medicine
University of Pennsylvania
Title: Imaging Analytics for Neuro-Oncology: Towards Computational Diagnostics
Central nervous system (CNS) tumors come with vastly heterogeneous histologic, molecular, and radiographic landscapes, rendering their precise characterization challenging. The rapidly growing fields of biophysical modeling and radiomics have shown promise in better characterizing the molecular, spatial, and temporal heterogeneity of tumors. Integrative analysis of CNS tumors, including clinically acquired multi-parametric magnetic resonance imaging (mpMRI), assists in identifying macroscopic quantifiable tumor patterns of invasion and proliferation, potentially leading to improved (a) detection/segmentation of tumor subregions and (b) computer-aided diagnostic/prognostic/predictive modeling. This talk will touch upon example studies on this space, as well as an overview of the largest to-date real-world federated learning study to detect brain tumor boundaries.
Daniel Marcus, PhD
Professor of Radiology
Director of the Neuroinformatics Research Group
Director of the Neuroimaging Informatics and Analysis Center
Washington University
Abstract:
Developing and deploying computational tools for neuro-oncology applications includes a sequence of complex steps to identify appropriate images, assess image quality, annotate, process and other prepare and manipulate data for analysis. We have implemented services and tools on the open source XNAT informatics platform to automate much of this workflow to improve both its efficiency and effectiveness. Dr. Marcus will discuss this automated workflow and its implementation in a number of data sets and applications at Washington University.
Lena Maier-Hein, PhD
Head of Department, Computer Assisted Medical Interventions
Managing Director, Data Science and Digital Oncology
Managing Director, National Center for Tumor Diseases
German Cancer Research Center
Title: Missing the (Bench)mark?
Abstract
Machine learning has begun to revolutionize almost all areas of health research. Success stories cover a wide variety of application fields ranging from radiology and gastroenterology all the way to mental health. Strikingly, however, solutions that perform favorably in research generally do not translate well to clinical practice, and little attention is being given to learning from failures. Focusing on biomedical image analysis as a key area of health-related machine learning, this talk will present pitfalls, caveats and recommendations related to machine learning-based biomedical image analysis. As a particular highlight, it will cover yet unpublished work on two key research questions related to biomedical image analysis competitions: 1) How can we best select performance metrics according to the characteristics of the driving biomedical question? And 2) Why is the winner the best? The results have been compiled based on the input of hundreds of image analysis researchers worldwide.
Lauren Oakden-Rayner, PhD
Director of Research in Medical Imaging
Royal Adelaide Hospital
Senior Research Fellow
Australian Institute for Machine Learning
Title: Medical AI Safety – A Clinical Perspective
Abstract:
Medical artificial intelligence is rapidly moving into clinics, particularly in imaging-based specialties such as radiology. This transition is producing many new challenges, as the regulatory environment has struggled to keep up and AI training for healthcare workers is virtually non-existent. Dr. Oakden-Rayner will provide a clinical safety perspective on medical AI, discuss a range of identified risks and potential harms, and discuss possible solutions to mitigate these risks as this exciting field continues to develop.
Bio:
Dr. Lauren Oakden-Rayner (FRANZCR, PhD) is the Director of Research in Medical Imaging at the Royal Adelaide Hospital and is a senior research fellow at the Australian Institute for Machine Learning. Her research explores the safe translation of artificial intelligence technologies into clinical practice, both from a technical and clinical perspective.
David Magnus, PhD
Thomas A Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics, Medicine, and by courtesy of Bioengineering
Director, Stanford Center for Biomedical Ethics
Associate Dean for Research
Stanford University
Title: Ethical Challenges in the Application of AI to Healthcare
Abstract:
This presentation will focus on three issues. First, applying AI to healthcare requires access to large data sets. Data acquisition and data sharing raises a number of challenging ethical issues, including challenges to traditional understandings of informed consent, and importance of diversity and inclusion in data sources. Second, I will briefly discuss the widely discussed issues around justice and equity raised by AI in healthcare. Finally, I will discuss challenges with ethical oversight and governance, particularly in relation to research development of AI. IRB’s are prohibited from considering downstream social consequences and harms to individuals other than research participants when evaluating the harms and risks of research. This gap needs to be filled, particularly as dual uses of AI models are now recognized as a problem.
Bio:
David Magnus, PhD is Thomas A. Raffin Professor of Medicine and Biomedical Ethics and Professor of Pediatrics and Medicine and by Courtesy of Bioengineering at Stanford University, where he is Director of the Stanford Center for Biomedical Ethics and an Associate Dean of Research. Magnus is member of the Ethics Committee for the Stanford Hospital. He is currently the Vice-Chair of the IRB for the NIH Precision Medicine Initiative (“All of Us”). He is the former President of the Association of Bioethics Program Directors, and is the Editor in Chief of the American Journal of Bioethics. He has published articles on a wide range of topics in bioethics, including research ethics, genetics, stem cell research, organ transplantation, end of life, and patient communication. He was a member of the Secretary of Agriculture’s Advisory Committee on Biotechnology in the 21st Century and currently serves on the California Human Stem Cell Research Advisory Committee. He is the principal editor of a collection of essays entitled “Who Owns Life?” (2002) and his publications have appeared in New England Journal of Medicine, Science, Nature Biotechnology, and the British Medical Journal. He has appeared on many radio and television shows including 60 Minutes, Good Morning America, The Today Show, CBS This Morning, FOX news Sunday, and ABC World News and NPR. In addition to his scholarly work, he has published Opinion pieces in the Philadelphia Inquirer, the Chicago Tribune, the San Jose Mercury News, and the New Jersey Star Ledger.